‘...The legal marijuana market is exploding...’
— Business Insider Australia
This is your final warning.
Last year, when Australia legalised the production of medicinal marijuana, investors rejoiced.
But that had nothing on what is going to happen to the burgeoning Australian medicinal marijuana industry in 2018.
I believe that if you want to take your last chance to make mind-blowing money on the fresh marijuana industry…
You need to get in before April 2018.
On 5 February, both the House and Senate reconvene for the first time this year.
And they could pass this LIFE-CHANGING legislation within just a few weeks.
See, at the start of the new year, Health Minister Greg Hunt made an announcement that gave me goosebumps.
‘We would like to be, potentially, the world’s number one medicinal cannabis supplier’.
I wasn’t the only one with chills.
Within 24 hours, ASX stocks with their hands in the marijuana market started to surge.
This time, Medlab shot up another 40% in eight days.
My stock pick made a massive 125% in under a week.
But the gains we’ve seen so far are a pittance compared to what’s coming.
If you aren’t already in, you’re wasting precious time.
When the pollies get back to work on 5 February, one of the big items on their agenda is legalising the export of Australian medicinal marijuana.
And it could happen FAST.
Because this topic has created a genuine Australian miracle:
This legislation could come into effect within weeks of its introduction.
When they legalised medicinal marijuana for the Australian masses, for the Aussie public, they did not have the same unanimous support.
That legislation took 78 days.
So my estimation of April is really quite modest. This could even kick-off sooner.
Take the same-sex marriage legislation.
After the Australian public voted, parliament next sat on 27 November.
The bill had passed by 8 December. Just 12 days later…
I know our pollies tend to move slowly. Sometimes VERY slowly.
But I don’t think this will be one of those times.
Greg Hunt and his mates are trying to set us up for a monopoly over the entire global marijuana market.
That means one thing for investors:
The biggest gains could be exclusive to the first-movers getting in before my forecast of April.
The potential for the Australian medicinal marijuana market is estimated at $1 billion.
But the global market? That could get up to $35 billion within the next two years.
I don’t want you to miss out on the kind of cash this could light up.
I call it the biggest ‘legal drug deal’ in history…
In this letter, I’ll hand you all my research on the Aussie stock market’s MARIJUANA MESSIAH I believe is set to lead the boom.
And if you’ve got the guts — and a few coins in your pocket to play with — this tiny pot stock has the power to potentially nab you a high-bagger gain as the global marijuana market heats up.
An Australian cardiologist quoted by news.com.au has said that legalised marijuana is ‘the next big thing in medicine’.
That’s certainly what’s playing out in America right now.
29 states in the US have fully legalised medical marijuana. A move that’s unleashed a torrent of wealth for quick-thinking investors.
Take a look at these beauties…
GW Pharmaceuticals shot up 1,380%, Insys Therapeutics ran up 1,102% and Abattis Bioceuticals soared as high as 13,627%.
And that’s just the start. I’ll show you more gains just like these as we go.
But here’s the point, every one of the point: Every those huge gains kick-started the moment legal pot got the nod from Capitol Hill for the US market.
Australia is making the same moves RIGHT NOW, for the US and beyond.
Canberra paved the way for legal medicinal marijuana.
Any minute now, the government could start handing out permits for international exports.
And I believe I’ve found two stocks set to make landmark gains on this new venture.
I honestly believe my favourite pick could be looking at gains of up to 1,233%.
But if you want ‘in’ on Australia’s ready-to-explode marijuana market you need to grab your stake now.
I reckon by 24 April 2018, a buying frenzy in this stock could well be underway…and it could send shares in this unheard-of marijuana play — selling for barely over 11 cents apiece today — soaring multiples higher.
This is the sort of radical, ground-floor investment play you’ll be telling your grandkids about. A tiny ‘pot punt’ that could turn $500 into thousands of dollars.
I’ve researched every inch of the marijuana market, hunting down its hottest prospects. What I’ve uncovered has blown me away:
I know, I know. Those gains sound ridiculous. But they’re not misprints.
All those huge gains were clocked up within the last three years. As you’re about to see, it’s just a hint at what’s coming…
Because the money that will be pouring into legal marijuana in the next 12 months borders on ridiculous…
Follow my lead today and I believe you could be right there, watching your tiny pot grubstake balloon into a small marijuana fortune.
By 2020, it could hit an estimated $35 billion.
That’s not a random number pulled from thin-air. It comes straight from Bank of America Merrill Lynch.
And many experts believe the global marijuana market could eventually reach $270 billion.
Source: Australian Small-Cap Investigator
$270 BILLION! Let me put that into perspective for you…
The diabetes devices market is expected to reach around $35 billion by 2024. Cancer drugs top the scales at $107 billion. And HIV treatments came in at $20 billion in 2013.
In other words, the global marijuana wealth build-up could be bigger than all the drugs sold for diabetes, cancer and HIV…COMBINED!
There’s a jaw-dropping amount of money on the table. Marijuana is in a rapid-fire growth stage, and the biggest gains are yet to come. There’s no sign of the global marijuana market slowing down anytime soon.
Which is exactly why the world’s biggest companies and wealthiest investors are throwing hundreds of millions of dollars into marijuana right now:
I believe the fast-growing marijuana industry expansion could be a ‘huge deal’ for your net worth too.
You’re staring down the barrel of a certified ‘green rush’ that — as The Australian Financial Review puts it — is about to ‘light up pot stock boom.’
The unheard-of Aussie marijuana stock I’ll show you in a moment is right at the heart of this boom.
Put a few dollars on it now ($500 is all you need!) and it could deliver you a life-changing amount of wealth that outpaces anything we’ve seen emerge from the Aussie health sector thus far.
And that’s really saying something. Because the gains from some of Australia’s big healthcare players are huge…
Well-known Aussie healthcare firms like CSL, Resmed and Cochlear have created mega-wealth for patient investors.
The breakthrough technologies they’ve created have saved countless lives and generated huge stock gains:
Source: Port Phillip Publishing
Source: Port Phillip Publishing
Source: Port Phillip Publishing
But here’s the thing…
Those gains unfolded over years…decades even.
The legalised marijuana market is growing so fast, and the demand for life-saving marijuana solutions is so great, I think the little-known Aussie marijuana firm I’ll introduce you to shortly could break similar gains…but in a matter of months.
That’s not conjecture.
I can’t stress enough that once legislation hits parliament, this thing could fly through. And I believe that this legislation could very well pass BY 24 APRIL.
Fact is, for switched-on investors who had the foresight to catch the marijuana train early…the big gains are already stacking up fast:
Source: Yahoo Finance
Source: Google Finance
Source: Yahoo Finance
Eye-watering gains, yes?
Remember though, the above stocks are fresh examples inside a — ahem — ‘green’ healthcare sub-sector.
Which means they’re a lot riskier than your everyday blue-chip healthcare stocks like CSL, Resmed or Cochlear.
And you should only ever use money on higher risk small-cap stocks that won’t ‘break the bank’.
But where there’s higher risk, you’ve also got a potential shot at creating immense fortunes.
Take another look at the last Aussie marijuana stock I showed you, MGC Pharmaceuticals. In 26 months, shares flew up 1,233%.
A small $500 punt turned into $6,165 in just 26 months. Enough to walk out the front doors of Harvey Norman with a brand-spanking-new, 75 inch Sony Bravia HD TV under your arm.
If you’d had a little more money to risk — say $5,000 — you’d have $61,650 sitting in your brokerage account right now. The kind of money that lets you deck out a whole private cinema room in your home…or even put a deposit down on a new house!
Again, exciting as those gains sound…I believe it’s nothing more than a dress rehearsal for what comes next.
See, a crucial medicinal marijuana export licence has the power to really lift these early movers. This could make gains already racked up by Australia’s early ‘pot plays’ like MGC Pharmaceuticals, Botanix and Medlab look tiny.
Few mainstream analysts understand the magnitude of this announcement…
Fewer still know what it means for the fortunes of one specific pot stock at the centre of Australia’s fledgling marijuana industry.
In short, it could see this tiny marijuana stock grab a big slice of an international medicinal marijuana market that Bank of America Merrill Lynch estimates could be worth as much as $35 billion in the next three years. Or more…
That’s why you need to look at this now. By the end of April, your chance to PROFIT from this could be gone.
Right now, this company’s market cap is just $66 million. While that sounds big, in market terms that’s tiny.
But picture this…
Just 1% of that $35 billion marijuana market ($350,000,000!) would instantly re-rate this firm’s market value — and its shares — SEVEN-FOLD.
And that’s only the start.
Motley Fool reports legal marijuana could soon rival the ‘$200 billion alcohol industry’.
Bottom line: This is your shot to jump on an emerging market move you won’t see again in your lifetime.
Position yourself at the centre of this global boom now with this Aussie marijuana stock and I believe you could make a certified fortune. Here’s how…
Medical marijuana is white-hot right now.
In the last two years, a hard and fast mission to relax marijuana laws globally has opened-up a series of money-gusher pot opportunities for quick-thinking investors.
I’m talking potential gains like 3,429%, 7,367% and even 36,412%.
The US and Canada lead the way to end marijuana’s prohibition. Look at this:
In the US, 29 states have legalised medical marijuana…
16 American states have decriminalised marijuana…
And eight states (including the District of Columbia) have made both recreational and medical marijuana 100% legal…
You can see on the chart below. Legal marijuana is sweeping across America.
In Canada, the story is just as sweet…
Canada’s prime minister is all set to greenlight medical and recreational marijuana by the Canadian summer THIS YEAR:
As soon as June, every Canadian citizen will be able to legally access legal medical marijuana, or light up a joint recreationally.
Marijuana’s prohibition is coming to an end!
Demand for high-quality medical marijuana is surging. It’s a feeding frenzy. I’ve never seen anything like it.
But here’s the really crazy news. In 2018, demand for Australian marijuana could kick up to a whole new level, and it could happen very soon.
Now, I need you to pay close attention here, because this is where your opportunity to profit from our market domination heats up to a scorcher…
It’s not often I give the government a pat on the back.
Too often they meddle in our lives.
And they almost always do what they can to gouge at your wealth.
But this is a rare exception.
Because the Turnbull government is about to hand a few first-mover Aussie marijuana firms a shot at the soon-to-be $200 billion international marijuana market.
And the next ‘marijuana messiah’ I want to tell you about today could be first in line to profit.
I believe this could be the Aussie underdog to lead our take down of the entire global market.
This could be your last chance to get in on the ground floor of the biggest pot stock profits in Australia.
I’ll tell you more about the deal in a second. First, here’s an important question you need to answer for me right now…
See, Australia’s newly crowned ‘pot god’ and his pot-producing friends could soon be handed the keys to a global medicinal marijuana industry that could soon top $200 billion.
It’s a watershed moment for Australia’s fledgling marijuana industry.
This government-sanctioned deal potentially hands our tiny pot punt a direct line into a multibillion-dollar global marijuana market…
And it could propel the share price of the pot stock I’ll show you, many multiples of where it is today.
But if you want a chance to take home the biggest and fastest gains, you need to grab your stake now, before news of the pot god’s newly minted export license hits mainstream airwaves.
Listen, every time a country passes new marijuana legalisation laws it creates new rapid-growth business opportunities, jobs and fortunes for canny investors.
And this could put Australia in command of the whole lot of them.
I’m sure I don’t need to tell you twice that this could make you a small fortune if you play it the right way. I’ll show you how it’s possible.
I’ve bundled all my research on Australia’s new marijuana messiah into a just-published investor briefing. It’s called: ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’.
I’ll show you how to download your copy in just a moment.
First, let me show fill you in on what qualifies me to write about opportunities like this…
My name is Sam Volkering.
I’ve been in the investment business for over a decade. But thanks to my accountant grandfather, I knew what a balance sheet and profit and loss were when I was 12.
Funnily enough, this led me to a career in advice. Starting out as a financial advisor in the suburbs of Melbourne, helping everyday people manage, invest and grow their wealth.
That led me to taking up a Certified Financial Planner™ role in one of Melbourne’s fastest growing wealth-management firms.
It was here I advised high net-worth clients on how to invest their wealth, as well as establishing and sitting as Chairman of the in-house Investment Committee.
This makes me a fully-accredited adviser in shares, options, and warrants.
But it didn’t take long to realise that the Financial Planning world in Australia is fatally flawed. So I got out. And I uncovered perhaps the most exciting job in the world at Port Phillip Publishing — which is why I’m writing to you today.
Today, I use all my knowledge and experience to help ordinary folks profit from the most speculative (and potentially lucrative) stocks on the planet: Small-cap stocks.
I do this through my newsletter, Australian Small-Cap Investigator.
The shares I cover have small ‘market capitalisations’ — usually with stock market values well under $200 million.
While they may be small, they also have huge potential. And it’s my job to find the stocks I believe could make you huge three and four digit gains.
That’s why I’ve focused all my resources to find the greatest small-cap stock in the marijuana industry. And I’ve vetted what I believe is the single best Australian marijuana play you can make today.
This is a company already tied directly to both the domestic AND massive, multi-billion-dollar international marijuana markets.
Demand for quality legal marijuana is surging higher every single day. And I believe this ASX-listed company is set to race toward ‘10-bagger’ gains in the months and years ahead.
How can I be so convinced?
Well, judging by the feedback I’ve received from my readers, I know a thing or two on how to make big money from fast-moving small-cap stocks…
Daniel Magee is a recent example. He just made roughly $170,000 in around two years on a small-cap water treatment tech pick:
‘Just like to say thanks for the recommendation.
‘I loved the story and researched it thoroughly and was convinced by what I found.
‘I made over 170k in about 2 years with little initial capital from a part time job, and for a university student just about to start working I am set!
‘All my friends and colleagues ask me how I did it and are stunned that some days I was gaining tens of thousands of dollars.’
Graham Dietrich emailed me about the same stock: ‘I’m up 400% on stock that cost me nothing!’
Jaspreet Singh, a long-time follower of our recommendations, recently emailed to say:
‘I am delighted, both at a personal and financial level, to report that one of my largest profits as per your recommendation has been xxx
‘I bought 60,000 shares at $0.05 and as of 06/06/2016 am sitting on an 830% profit of $24,900.
‘I must also add that I have few other mega profits by following your recommendations on xxx (800% +) and xxx (243%).
‘So all in all I am a very satisfied subscriber — keep up the sensational work.’
Mike Burrell writes, ‘Great recommendation. I made a tidy profit off a simple $500 buy-in… keep up the great work.’
And this from Nigel, ‘G’day Sam. Bellamy’s turned out to be a nice little earner… Total $108,170 or 558%. Thanks!’
I think the marijuana stock I’ll introduce you to next could be a ‘nice little earner’ for you too.
Imagine staking a couple of grand on this tiny pot punt, and watching that small amount of money quickly build up to a six-figure small-cap fortune…just like Nigel.
Well, you may not have to imagine for too much longer. By 30 June I predict this unheard-of pot play will soar multiples higher.
Fact is, if you can find quality Aussie pot stocks tethered to the $270 billion international marijuana market, and you get in before the mainstream catch a sniff, it could be like winning the Powerball jackpot!
Let me explain fully by showing you the most exciting pot play on the ASX today. At the time of writing, shares in this company sell for around 11 cents. By the end of the financial year you could see the same shares swapping hands for $1…or MORE.
This is a white-hot market right now.
Some companies are seeing extraordinary gains on nothing more than a fancy PowerPoint presentation and vague ASX announcement. That’s concerning.
But there are also a select number of stocks involved in medicinal marijuana that are truly cracking little companies.
I sincerely believe this stock is one of them.
It has the same kind of eye watering stock-gain potential as MGC. You’ll remember MGC went on to hit gains up to 1,233%. In fact, I think this stock has even BIGGER potential.
They’re on a mission to become Australia’s leading medical marijuana producer for the therapeutic market.
The focus is to grow and sell medical-grade pot to people who suffer from terrible health conditions like Parkinson’s disease, chronic neuropathic pain, chronic pain and treatment resistant epilepsy.
Medical marijuana has proven to ease these chronic pain conditions. And in the case of severe epilepsy, reduce epileptic seizures significantly.
It’s a huge sigh of relief for people like Cheri O’Connell.
Cheri’s 10-year-old daughter, Tara, suffers from a life-threatening form of epilepsy called Dravet syndrome.
Before her life-saving medical marijuana treatment, Tara suffered from up to 200 seizures A DAY and wasn’t expected to live past here ninth birthday.
‘Now…’ says Cheri ‘she’s walking, talking, running, reading — all those things that we just never thought possible.’
Now with all the legal marijuana wrangle at an end…and the federal government signing off on medicinal marijuana…people like Tara’s mum Cheri no longer needs to risk a stint in jail to get their hands on life-saving, medical marijuana.
It’s a watershed moment. And it’s the main reason our new Aussie pot pioneer is rushing to get its marijuana to market.
This particular Aussie small cap has more partnerships than almost any other pot stock. And they are with some of the best pot pals not just in Australia, but around the world.
In fact, these partnerships have allowed this little company to profit on the global market before the export permissions come into effect. Nonetheless, these permissions will turn those strategies up to the max.
But that isn’t the biggest reason to take note of this little entrepreneur.
Here’s what’s got me fizzing with excitement about Australia’s marijuana messiah…
See, this tiny $68 million dollar Aussie company is undertaking research that could take them beyond medicinal marijuana. In fact, this could catapult them to the front of a $50 TRILLION INDUSTRY.
That’s how much two University of Chicago researchers estimated would be the value of curing cancer.
Yep, this small Aussie company have set their sights on eradicating cancer…
And so far, the research has been positive.
Those same researchers from Chicago estimated that ‘a 1 percent reduction in mortality from cancer has a value to Americans of nearly $500 billion’.
Just tackling 1% of cancer mortalities in America could send shares in this company almost 10,000x higher.
And save some lives in the process!
What’s so special about medical marijuana?
For thousands of years, the cannabis plant has been used to treat common ailments such as rheumatism, gout, malaria, and intestinal worms.
But more recently scientists have discovered dozens more conditions cannabis (and the cannabis compound tetrahydrocannabinol) can treat. Here’s just a sample:
Cannabis Kills Cancer
There are many studies that have conclusively shown that cannabis not only slows down cancer, but kill cancer cells, and shrinks tumours.
Tetrahydrocannabinol (THC) stops the build-up of beta-Amyloid plaque in the brain that causes Alzheimer’s. THC can even reverse the damage Alzheimer’s causes.
A strain of medicinal marijuana given to rheumatology units at several hospitals, caused a significant reduction in inflammation and pain.
THC binds to the brain cells responsible for controlling excitability and relaxation. It is now considered the most effective medicine for reducing or eliminating epileptic seizures.
MS sufferers have found cannabis reduces pains and muscle contractions associated with the diseases.
Studies conducted in Israel show cannabis use can improve fine motor skills and reduce tremors in Parkinson’s patients.
You should know, the company only listed on the ASX in November 2016. So there’s not a whole lot of history to go on.
Which is primarily what makes this pot stock high-risk.
While you’ve got a great shot at a potential marijuana windfall, there’s also a chance your shares could fall to zero. So, only invest ‘play’ money. It’s not a stock you want to bet your savings on.
I don’t believe your stake will turn to dust, though.
This is a company on the razor’s edge of the entire global marijuana and biotech markets. If you’ve got a little money to spare, now’s the time to go ‘all in’ on Aussie marijuana.
Grab your share in this Aussie pot stock today and…
I’ve compiled everything you need to know about Australia’s new ‘pot god’ in a brand-new investment research report.
This special investment briefing is called: ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’.
And I want to send you this report immediately, just for trying out my advisory Australian Small-Cap Investigator for the next 30 days.
In this special briefing you’ll find all the details on my favourite Aussie marijuana pick, including the stock ticker symbol, buying instructions and risks.
You’ll have full access to a complete and thorough analysis of the Aussie marijuana stock that I believe could deliver 1,000%-plus windfall profits to investors.
If you want a big piece of this ‘green’ gold rush, ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’, is your ticket.
If you’re ready to jump on-board, click here now to claim your copy.
By the way, you should know I believe the potential for 1,233% gains is a conservative estimate.
Because if the gains clocked up by international marijuana growers are anything to go by, you could make more (A LOT more!) than 1,233%.
Here’s what I mean…
When CGrowth Capital announced they were moving into marijuana cultivation, their stock shot up 3,000% in 2016.
Source: Yahoo Finance
Pretty good, right?
Well, not as good as United Cannabis Corporation.
A grower of genetically refined strains of medical-grade cannabis plants.
In early 2014, it was trading for about $.06 a share…
By early April the same year, $10.50.
United Cannabis shot up 16,700% over the course of two months!
Source: Yahoo Finance
Yes, you read that right, United Cannabis Corporation zipped 16,700% higher...In only two months!
But it doesn’t come close to Supreme Pharmaceuticals.
By October 2016, this stock had roared (and no, this is not an error) 51,510%!
Source: Google Finance
Now, I’m not saying the Aussie marijuana punt I’ve shown you today will rack up a five-figure gain overnight. Past performance is never a guarantee of future results.
And frankly, gains like Supreme Pharmaceuticals are ULTRA rare.
You’d be lucky to see a gain like that once in three lifetimes. So, I can’t guarantee you’ll ever see a gain like Supreme’s five-digit gain haul.
But I DO believe you have a chance at this very moment to make a few small moves that could reward you with a life-changing fortune.
Lay down just $500 on the pot punt you’ll find inside ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’, and if it rises only 1/60th of that Supreme gain, you’ll be telling that story for the rest of your life.
All my analysis on the Aussie ‘pot god’ is packed into your fully downloadable, password protected PDF document: ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’.
Your copy is waiting for you right now.
If you’re as excited as I am by the wealth-building potential baked into the global marijuana market, click here to claim your copy of my special marijuana report now.
But before you make your final decision, there are TWO MORE white-hot pot opportunities I want to expose you to today.
The marijuana messiah you’ve seen today is — in my humble opinion — the best Aussie pot stock on the market right now.
I believe it’s the best Aussie-based option to rival the huge gains popping up from a handful of companies in the fast-growing US marijuana market.
But as you’ve probably picked up, it’s far from the only pot stock jumping on the ASX.
By my count there are up to 20 marijuana companies on the Australian stock market today…more will likely follow.
But that doesn’t mean just any pot stock is ‘investment worthy’. Far from it. You’ve got to be ultra-selective in which marijuana firms you trust with your money.
I’ve no doubt medicinal marijuana will prove a massive, multi-billion-dollar Australian industry. You can look to the US and Canada for a sneak-peek at just how big marijuana could be Down Under.
And I believe Australia’s marijuana messiah will lead the way as the Aussie pot gathers speed.
But there’s another stock snapping at its heels that could land you another ‘high-bagger’ gain as Aussie pot winds up for a huge and imminent growth spurt.
But your second pot domination punt is a little different to the other one.
Their ‘modus operandi’ is to become the dominant player in a non-human — yes, NON-HUMAN — $40 billion niche market screaming for top-notch medicinal marijuana products…
Most marijuana firms develop cannabinoid treatments for human consumption.
That’s the path 99% marijuana companies walk right now.
NOT your second play…
This company has pivoted toward what may turn out the world’s hottest, wealthiest, non-human marijuana market.
They’ve established first-mover advantage inside an existing market that ON ITS OWN is set to reach US$39.7 billion by 2021.
It’s a smart move. One that I believe could reward early investors with seven-fold gains…
That’s short term…
Long term, I’m not putting a cap on this company’s potential. They’re doing so much right — SO MUCH — you could see this stock crack 1,000%-plus gains next year.
I mean that.
If this tiny pot play’s future plans come together…a couple of years from now, you’ll find their products in the home of every pet owner…and every veterinary clinic on the planet.
Yes, I said veterinary…
See, this clever little pot firm is poised to become THE dominant global player in medical marijuana for pets.
Pot for pets? Really?
Sounds a little weird, right?
But sit on it a moment…
Is it REALLY all that weird?
There are more than 25 million pets in Australia. 63% of Aussies own a family pet. For many of us, a pet IS family.
Like us, our furry friends suffer from degenerative diseases and medical conditions…especially with advanced age.
No one wants a pet to suffer. A few drops of the marijuana-based solutions developed by this company could relieve — even possibly cure — animals ravaged by disease and illness.
Mordor Intelligence research suggests that the global veterinary healthcare market could be worth a scorching US$39.7 BILLION within the next three years.
And if you’ve ever darkened a vet’s door with your moggy or Fido, I’m sure that won’t surprise you!
The pot-based animal nutraceuticals developed by your second pot domination play target conditions like anxiety (linked to separation, loud noise, travel and crowds)…
Pain (acute and chronic)…
Inflammation, arthritis, allergic skin conditions, and other conditions such as diabetes.
But their biggest breakthrough at the moment is a medication that relieves symptoms of osteosarcoma, a common bone cancer in our pooch pals.
Imagine being able to sooth your best puppy pal…
This is by far the smallest marijuana punt on my list. And the smaller of your two pot plays.
Their entire market cap sits at a shallow $9.35 million.
Right now it’s less than 8% the size of the king pot stock I’ve introduced you to today.
A position that is changing…RAPIDLY.
See, what the company lacks in sheer size, it more than makes up for in deal-making power…
In a matter of months, they’ve shaken hands on several potentially lucrative partnerships:
These announcements are great news. But it’s a growing bottom line that’ll support a fast-rising share price.
The first round of product sales are due to land in the next 12 months. And this new export deal could see that Australian and European potential market increase tenfold by the time product hits the shelves.
It’s clear they’re on a mission for global dominance. A mission that could help you to a potential 653% gain in the months ahead if you jump on this pot stock now.
Look, I can’t make this any clearer to you today.
You’re at the beginning of an investment opportunity matched in wealth potential only by the early 2000s tech boom…or Australia’s just-finished mining boom.
Both booms birthed multiple ‘high-bagger’ stock punts. I’m talking about companies that climbed five, eight, even 10 times higher.
Today’s marijuana boom — in my view — will be just as lucrative. Well, it will be for the smart investors who recognise an opportunity when they see it and board the ‘pot train’ early.
That’s not some wild claim, either.
The first marijuana stock I tipped way back when it hit Australian shelves is already sitting on 511%.
This export deal could be your last chance to score those kind of profits on this landmark movement.
The marijuana industry is still in its infancy. But I’m predicting it won’t be long before it matches…then overtakes...the booze industry. That might sound like an outlandish prediction. But I’m not the only one who thinks so:
So, if you want to be part of an opportunity that could hand you an early retirement, you need to open your eyes and act fast.
Don’t be the investor that looks back on the mature marijuana industry in 10 years and wishes they’d had the stomach to put a little money on legal marijuana when it was still finding its feet.
You can’t put this one on hold. The time to act is now.
This is your chance to claim an early (and potentially ultra-lucrative) stake in Australia’s bubbling cannabis export boom.
You can download your special pot briefing: ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’ immediately from my private, members-only website.
Inside you’ll find all my research and analysis on the two ready-to-burst Aussie pot stocks I’ve shown you today.
All I ask in return is that you…
Here’s how it works.
A one-year subscription to Australian Small-Cap Investigator costs $99.
That’s a steal.
In 2017, my subscribers sold out on not one but TWO stocks with over 1,000% gains.
You don’t need to throw tens of thousands of dollars at my recommendations.
If you’d been on board for just one of those plays, you’d have turned every $500 you put down into up to $6,795!
So, $99 is nothing compared with the opportunities my research could give you every month.
But today, I’m going to cut that in half.
Start your 30-day, no-obligation trial now and you’ll pay just $49 for your first year.
That works out at just over $4 a month.
I don’t want price to put you off. I want you plugged into my research now.
And I want you in on this pot punt before the share price races away.
And right now, it’s within a hair of my buy-up-to limit.
That’s a strict limit I impose to make sure you don’t pay too much for a stock…and that you have the best possible chance of making a great gain.
So, if you want in on this, now is the time.
Do not delay.
You’ll go through to a 100% secure order page.
Enter your credit card details.
We’ll charge you just $49 for your first 12 months and, within half an hour, you’ll have your own private password to access all of my research.
But hang on…
Your trial membership doesn’t end at the pot stock you’ve seen today. Not by a long shot.
There’s a whole lot more I’d like to give you when you trial Australian Small-Cap Investigator for the next 30 days…
Every month, I research and recommend new small-cap plays. I believe each one has the potential to make you a great profit.
That means I’ve amassed a wealth of information about small-cap investing. And I revel in sharing those resources with my readers.
The investment resource I want to share with you today ranks as the most important (and for you, potentially lucrative) of my career.
As soon as you join today, you’ll receive instant access to my special marijuana intelligence report: ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’.
Your password protected dossier includes every piece of research and analysis I’ve compiled on two Aussie pot stocks I believe have a genuine chance at making you a small fortune in the months ahead.
Hold these stocks for the long-term and you could be looking at a legacy-making amount of wealth. Just from these two stocks alone!
As you’ve seen today, the beginning of Australia’s pot domination is here, and it’s making handfuls of wise investors RICH. Some pot stocks, like Supreme Pharmaceuticals, have amassed gains for early investors of 50,000%-plus!
Every time a country or state legalises marijuana, a whole new wave of wealth is unleashed. I see the same wealth-trend unfolding in Australia starting now.
Your best shot to take advantage of the fledgling Aussie marijuana boom is by ‘test-driving’ Australian Small-Cap Investigator today, and immediately downloading your copy of ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’.
Inside you’ll find the ticker symbol for each stock, all the risks, as well as all the potential rewards on offer from each pot play. And those potential profit-rewards on offer are colossal.
The first pot stock I’ll reveal inside your special marijuana dossier is a firm I’ve dubbed Australia’s marijuana messiah.
They’re on a mission to become a leading global medicinal marijuana farmer, and on-sell every scrap of medical-grade pot they cultivate into the therapeutic market.
They’re developing cannabis based drugs that can ease — and maybe someday cure — shocking health conditions like Parkinson’s disease, chronic neuropathic pain, cancer, multiple sclerosis and epilepsy.
In my view, they’re next in line to receive the thumbs up from the Turnbull government to export their products around the world. A decision that could see shares in this firm blast higher VERY quickly.
This is a bold little Aussie company I think could — conservatively — multiply your investment 13 times over in the months and years ahead.
In my view, your second pot domination play is poised to be the leader of pet-based medicinal pot products.
They’ve already established key partnerships with European distributors with plans to roll out no less than five products in Europe this year and across the globe in 2018.
This is the smaller of the two stocks you’ve seen today, but I believe you could still catch 653% gains from an early punt. Long term you could be looking at a potential 1,000%-plus pot stock.
Again, the potential rewards on offer from these two stocks alone are huge. Just $500 on each stock could balloon to $13,595!
But to have a shot at gains like those, you need to act now. These shares are cheap today. You can pick up shares in each stock for under $0.50 right now.
Mark my words, you won’t be able to buy them anywhere near this cheap as soon as a few weeks from now.
Some are already floating near my buy-up-to price so I truly cannot stress enough how time sensitive this is.
Don’t let this pot domination punt pass you by. Simply click here to be taken to a secure order page and you’ll receive immediate access to your special investor report: ‘The 2018 Pot Stock Frenzy: How You Could Pocket SIX TIMES your money as Aussie Pot Exports Take Flight’.
But I’m not done yet. I’d like to give you a few extra goodies when you trial Australian Small-Cap Investigator for the next 30 days…
Reversing ageing. It’s not science fiction any longer.
In fact, this technology is on its way to a hospital near you, and if you act quickly, you could profit whilst turning back the clock.
Inside ‘Ignition Point’, I’ll show you how. You’ll learn:
Bonus Gift #2: ‘The Only System You Will Ever Need to Screen Potential Breakthrough Small-Cap Stocks’
This report explains my stock-picking strategy.
Inside, I reveal everything I look for in a small-cap stock in precise detail. Including a complete breakdown of how I determine whether any one stock is worth a punt.
Bonus Gift #3: ‘Capital Gain and Cash to Boot: The Secrets of Spotting Small-Cap Value’
This easy-to-read guide will help you grasp the essential tools for evaluating any stock...including P/E ratios, yield, net asset value, free cash flow and more.
Plus, it reveals many secrets behind my highly-profitable share risk-rating system.
Don’t worry — you don’t really need any of this. I’ll do everything for you. But this just explains exactly how I go about my analysis.
We have something extra for you as well — again, complimentary and yours to keep forever:
Bonus Gift #4: ‘How Creative Destruction Works to Make Small-Cap Investors Rich’
If you can identify and back the companies led by talented entrepreneurs driving new inventions, technologies and discoveries...I think you stand to do very well.
There hasn’t been time to go into this side of my research today...but it’s waiting for you in the weeks ahead.
All these reports are yours to keep, whether you decide to continue your subscription after your trial or not.
I want you to get the most out of this you possibly can.
The two Aussie pot domination stocks I’ve profiled for you today are already trading near my maximum buy-up-to price. Which means the potential for you to catch the biggest gains from these stocks dwindles by the hour.
That’s another thing about the new clutch of pot plays…they are going to move super-fast. Legal marijuana is the hottest commodity on the ASX right now. Everyone wants a piece.
So, if you want a chance to potentially bank a 10-bagger pot gain in the months ahead, I urge you to act now.
You’ve seen the money some of my readers have made from my work over the last couple of years.
You understand that no one can predict where the market will go in 2018. But you appreciate that certain stocks could absolutely rocket, no matter what happens.
And I hope that, having read this letter, you agree with me that you have nothing to lose by giving Australian Small-Cap Investigator a go right now.
You can’t sit on your hands on this one…
You can’t think about it…
If you want to squeeze maximum potential gains from the pot punts I’ve shown you today, I need your answer now.
I believe these stocks could begin to zoom higher any day now. And they could soon move far above my recommended buy-up-to price.
You need to jump on them now...before both stocks go vertical.
That’s it from me. I’ve shown you all I can.
My full research, analysis and detailed buying instructions for Australia’s newly-crowned marijuana messiah is waiting for you once you begin your 30-day trial membership for the special price of $49 for the first year (50% off what regular subscribers pay).
Remember, your subscription fee is 100% refundable for your first 30 days.
Click here to get started.
If you’re looking to get in on the ground-floor of what could be Australia’s next billion-dollar industry…and to take a small punt on an exciting pot stock with the power to multiply your money many times over…don’t waste another second!
Become an Australian Small-Cap Investigator member and let me help you make the most of Australia’s new billion-dollar marijuana industry starting RIGHT NOW.
Click the ‘subscribe now’ link below to get started (you can review your order before it’s finalised).
Don’t miss this once-in-a-lifetime shot to bank a small fortune from a ground-breaking marijuana opportunity.
I look forward to welcoming you on-board!
Editor, Australian Small-Cap Investigator
You Can Review Your Order Before It’s Final